Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Distinct roles of excitatory and inhibitory neurons in the medial prefrontal cortex in the expression and reconsolidation of methamphetamine-associated memory in male mice
    Published on 2024-05-10
    2 years ago
  • Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity
    Published on 2024-05-07
    2 years ago
  • Treadmill exercise training inhibits morphine CPP by reversing morphine effects on GABA neurotransmission in D2-MSNs of the accumbens-pallidal pathway in male mice
    Published on 2024-05-07
    2 years ago
  • Enhanced cognitive flexibility and phasic striatal dopamine dynamics in a mouse model of low striatal tonic dopamine
    Published on 2024-05-02
    2 years ago
  • Alterations in adolescent brain serotonin (5HT)1A, 5HT2A, and dopamine (D)2 receptor systems in a nonhuman primate model of early life adversity
    Published on 2024-04-26
    2 years ago
  • A large-scale c-Fos brain mapping study on extinction of cocaine-primed reinstatement
    Published on 2024-04-25
    2 years ago
  • Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis
    Published on 2024-04-24
    2 years ago
« Previous 1 … 59 60 61 62 63 … 143 Next »
Journal of Psychopharmacology
  • Prefrontal cortex and putamen grey matter alterations in cannabis and tobacco users
    Published on 2022-09-16
    3 years ago
  • Cell-based serum anticholinergic activity assay and working memory in cognitively healthy older adults before and after scopolamine: An exploratory study
    Published on 2022-09-13
    3 years ago
  • Cognition-enhancing effect of YL-IPA08, a potent ligand for the translocator protein (18 kDa) in the 5 × FAD transgenic mouse model of Alzheimer’s pathology
    Published on 2022-09-07
    3 years ago
  • Visualizing classification of drugs used in psychotic disorders: A ‘subway map’ representing mechanisms, established classes and informal categories
    Published on 2022-09-01
    3 years ago
  • Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review
    Published on 2022-08-26
    3 years ago
  • Escitalopram should be investigated in anorexia nervosa: Rationale and review of mechanisms
    Published on 2022-08-25
    3 years ago
  • Relationship between change in social evaluation learning and mood in early antidepressant treatment: A prospective cohort study in primary care
    Published on 2022-08-24
    3 years ago
« Previous 1 … 59 60 61 62 63 … 134 Next »
European Neuropsychopharmacology
  • Contents
    Published on 2023-01-07
    3 years ago
  • ECNP Calendar of Meetings
    Published on 2023-01-07
    3 years ago
  • Editorial Board
    Published on 2023-01-07
    3 years ago
  • Effectiveness of Fluvoxamine at preventing COVID-19 infection from turning severe
    Published on 2022-12-13
    3 years ago
  • Brain correlates of subjective cognitive complaints in COVID-19 survivors: a multimodal magnetic resonance imaging study
    Published on 2022-12-12
    3 years ago
  • Disrupting the nNOS/NOS1AP interaction in the medial prefrontal cortex impairs social recognition and spatial working memory in mice
    Published on 2022-12-11
    3 years ago
  • Is there such a thing as gambling dual disorder? Preliminary evidence and clinical profiles
    Published on 2022-12-11
    3 years ago
« Previous 1 … 59 60 61 62 63 … 154 Next »

   Pharma Pub